P63 short isoforms are found in invasive carcinomas only and not in benign breast conditions

Virchows Archiv

Volumn 456, Issue 4, 2010, Pages 395-401

  De Biase, Dario ^a   Morandi, Luca ^a   Degli Esposti, Roberta ^b   Ligorio, Claudia ^a   Pession, Annalisa ^a   Foschini, Maria P ^a   Eusebi, Vincenzo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b BELLARIA HOSPITAL   (Italy)

Author keywords

Alternative isoforms; Breast carcinoma; Molecular characterization; P63

Indexed keywords

ISOPROTEIN; PROTEIN P63; TUMOR MARKER;

ADULT; AGED; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BENIGN TUMOR; BREAST CARCINOMA; BREAST TUMOR; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN VARIANT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; EXONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEMBRANE PROTEINS; MIDDLE AGED; PHENOTYPE; PROTEIN ISOFORMS; TUMOR MARKERS, BIOLOGICAL;

EID: 77951255398     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-010-0900-1     Document Type: Article

References (22)

1. M Levrero VD Laurenzi A Costanzo, et al. 2000 The p53/p63/p73 family of transcription factors: overlapping and distinct functions J Cell Sci 113 1661 1670 1:CAS:528:DC%2BD3cXjvFGls7s%3D 10769197 (Pubitemid 30333115)
2. S Strano M Rossi G Fontemaggi, et al. 2001 From p63 to p53 across p73 FEBS Lett 490 163 170 10.1016/S0014-5793(01)02119-6 1:CAS:528: DC%2BD3MXht1Ort74%3D 11223031 (Pubitemid 32171935)
3. CE Barbieri JA Pietenpol 2006 p63 and epithelial biology Exp Cell Res 312 695 706 10.1016/j.yexcr.2005.11.028 1:CAS:528:DC%2BD28Xis1Wiu74%3D 16406339
4. A Yang M Kaghad Y Wang, et al. 1998 p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities Mol Cell 2 305 316 10.1016/S1097-2765(00)80275-0 1:CAS:528:DyaK1cXmsVyqt7c%3D 9774969 (Pubitemid 128379271)
5. HO Lee JH Lee E Choi, et al. 2006 A dominant negative form of p63 inhibits apoptosis in a p53-independent manner Biochem Biophys Res Commun 344 166 172 10.1016/j.bbrc.2006.03.128 1:CAS:528:DC%2BD28XjvFWns7c%3D 16616891
6. MP Foschini A Gaiba R Cocchi, et al. 2004 Pattern of p63 expression in squamous cell carcinoma of the oral cavity Virchows Arch 444 332 339 10.1007/s00428-003-0969-x 1:CAS:528:DC%2BD2cXivV2jsrw%3D 14997391 (Pubitemid 38553637)
7. MJ Urist CJ Di Como ML Lu, et al. 2002 Loss of p63 expression is associated with tumour progression in bladder cancer Am J Pathol 161 1199 1206 1:CAS:528:DC%2BD38Xotlyqu7w%3D 12368193
8. M Senoo I Tsuchiya Y Matsumura, et al. 2001 Transcriptional dysregulation of the p73L/p63/p51/p40/KET gene in human squamous cell carcinomas: expression of Delta Np73L, a novel dominant-negative isoform, and loss of expression of the potential tumour suppressor p51 Br J Cancer 84 1235 1241 10.1054/bjoc.2000.1735 1:CAS:528:DC%2BD3MXkt1Olu74%3D 11336476 (Pubitemid 32511342)
9. MP Foschini A Gaiba R Cocchi, et al. 2005 p63 expression in salivary gland tumours: role of DeltaNp73L in neoplastic transformation Int J Surg Pathol 13 329 335 10.1177/106689690501300404 1:CAS:528:DC%2BD2MXht1GhtL7N 16273188 (Pubitemid 41688594)
10. CJ Di Como MJ Urist I Babayan, et al. 2002 p63 expression profiles in human normal and tumour tissues Clin Cancer Res 8 494 501 11839669 (Pubitemid 34193969)
11. X Wang I Mori W Tang, et al. 2002 p63 expression in normal, hyperplastic and malignant breast tissues Breast Cancer 9 216 219 10.1007/BF02967592 12185332
12. JS Reis-Filho F Milanezi I Amendoeira, et al. 2003 Distribution of p63, a novel myoepithelial marker, in fine-needle aspiration biopsies of the breast: an analysis of 82 samples Cancer 99 172 179 10.1002/cncr.11061 1:CAS:528:DC%2BD3sXlsFeju7s%3D 12811858 (Pubitemid 36713637)
13. M Barbareschi L Pecciarini MG Cangi, et al. 2001 p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast Am J Surg Pathol 25 1054 1060 10.1097/00000478-200108000-00010 1:STN:280: DC%2BD3MvislShug%3D%3D 11474290 (Pubitemid 32685903)
14. JS Reis-Filho PT Simpson A Martins, et al. 2003 Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumour tissue microarray Virchows Arch 443 122 132 10.1007/s00428-003-0859-2 1:CAS:528:DC%2BD3sXmsVSiurg%3D 12884041 (Pubitemid 37056135)
15. I Matos R Dufloth M Alvarenga, et al. 2005 p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas Virchows Arch 447 688 694 10.1007/s00428-005-0010-7 1:CAS:528:DC%2BD2MXhtFKqt7zM 16012853 (Pubitemid 41571183)
16. Tavassoli FA, Devilee P (2003) WHO. Pathology and genetics of tumours of the breast and female genital organs. IARC Press, Lyon
17. CW Elston IO Ellis 2002 Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up Histopathology 41 154 161 10.1046/j.1365-2559. 2002.14691.x 1:STN:280:DC%2BD28%2Fks1Ohuw%3D%3D 12405947 (Pubitemid 41713015)
18. V Eusebi F Magalhanes JG Azzopardi 1992 Pleomorphic lobular carcinoma of the breast: an aggressive tumour showing apocrine differentiation Hum Pathol 23 655 662 10.1016/0046-8177(92)90321-S 1:STN:280:DyaK383nsFGqtw%3D%3D 1592388
19. EA Rakha TC Putti DM Abd El-Rehim, et al. 2006 Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation J Pathol 208 495 506 10.1002/path.1916 1:CAS:528: DC%2BD28XislCqt78%3D 16429394 (Pubitemid 43329336)
20. MM Koker CG Kleer 2004 p63 expression in breast cancer: a highly sensitive and specific marker of metaplastic carcinoma Am J Surg Pathol 28 1506 1512 10.1097/01.pas.0000138183.97366.fd 15489655 (Pubitemid 39425518)
21. Tavassoli FA, Eusebi V (2009) Tumors of mammary gland. AFIP Atlas of Tumor Pathology. American Registry of Pathology, Washington
22. MP Foschini R Cocchi L Morandi, et al. 2008 E-cadherin loss and Delta Np73L expression in oral squamous cell carcinomas showing aggressive behavior Head Neck 30 1475 1482 10.1002/hed.20908 18704970